JP2017536089A5 - - Google Patents

Download PDF

Info

Publication number
JP2017536089A5
JP2017536089A5 JP2017517081A JP2017517081A JP2017536089A5 JP 2017536089 A5 JP2017536089 A5 JP 2017536089A5 JP 2017517081 A JP2017517081 A JP 2017517081A JP 2017517081 A JP2017517081 A JP 2017517081A JP 2017536089 A5 JP2017536089 A5 JP 2017536089A5
Authority
JP
Japan
Prior art keywords
seq
binding
antibody
binding molecule
cells
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2017517081A
Other languages
English (en)
Japanese (ja)
Other versions
JP6875275B2 (ja
JP2017536089A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2015/072279 external-priority patent/WO2016050702A1/en
Publication of JP2017536089A publication Critical patent/JP2017536089A/ja
Publication of JP2017536089A5 publication Critical patent/JP2017536089A5/ja
Application granted granted Critical
Publication of JP6875275B2 publication Critical patent/JP6875275B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2017517081A 2014-09-30 2015-09-28 L1cam(cd17)と結合する抗体などの結合分子 Active JP6875275B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP14003383 2014-09-30
EP14003383.8 2014-09-30
PCT/EP2015/072279 WO2016050702A1 (en) 2014-09-30 2015-09-28 Binding molecules, especially antibodies, binding to l1cam (cd171)

Publications (3)

Publication Number Publication Date
JP2017536089A JP2017536089A (ja) 2017-12-07
JP2017536089A5 true JP2017536089A5 (cg-RX-API-DMAC7.html) 2020-01-30
JP6875275B2 JP6875275B2 (ja) 2021-05-19

Family

ID=51743255

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2017517081A Active JP6875275B2 (ja) 2014-09-30 2015-09-28 L1cam(cd17)と結合する抗体などの結合分子

Country Status (14)

Country Link
US (1) US10400037B2 (cg-RX-API-DMAC7.html)
EP (1) EP3200822B1 (cg-RX-API-DMAC7.html)
JP (1) JP6875275B2 (cg-RX-API-DMAC7.html)
KR (1) KR102554634B1 (cg-RX-API-DMAC7.html)
CN (1) CN107108741B (cg-RX-API-DMAC7.html)
AU (1) AU2015327064B2 (cg-RX-API-DMAC7.html)
CL (1) CL2017000756A1 (cg-RX-API-DMAC7.html)
DK (1) DK3200822T3 (cg-RX-API-DMAC7.html)
ES (1) ES2881575T3 (cg-RX-API-DMAC7.html)
MX (1) MX388698B (cg-RX-API-DMAC7.html)
PL (1) PL3200822T3 (cg-RX-API-DMAC7.html)
RU (1) RU2754684C2 (cg-RX-API-DMAC7.html)
SI (1) SI3200822T1 (cg-RX-API-DMAC7.html)
WO (1) WO2016050702A1 (cg-RX-API-DMAC7.html)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107118271B (zh) * 2016-12-21 2021-01-22 四川百利药业有限责任公司 可用于富集人l1cam蛋白的抗原多肽和单克隆抗体
WO2019165326A1 (en) * 2018-02-23 2019-08-29 REMD Biotherapeutics, Inc Calcitonin gene-related peptide (cgrp) antagonist antibodies
MX2020013923A (es) 2018-06-29 2021-03-29 Apitbio Inc Anticuerpos anti molécula de adhesión celular l1 (l1cam) y usos de estos.
US12036242B2 (en) 2018-07-05 2024-07-16 H. Lee Moffitt Cancer Center And Research Institute, Inc. CAR T cells that target B-cell antigens
CN108949997A (zh) * 2018-08-24 2018-12-07 南京求臻基因科技有限公司 一种肺癌检测标志物及诊断试剂盒
CN112010980B (zh) * 2020-10-13 2021-01-22 上海良润生物医药科技有限公司 重组抗cd171双特异抗体及神经来源外泌体的捕获方法
CN112239505B (zh) * 2020-10-13 2022-05-20 上海良润生物医药科技有限公司 重组抗cd171八价抗体及神经来源外泌体的捕获方法
WO2023078224A1 (zh) * 2021-11-03 2023-05-11 同润生物医药(上海)有限公司 新型抗l1cam抗体
CN114933636B (zh) * 2022-06-24 2023-05-09 浙江省人民医院 靶向l1cam的多肽及其应用
CA3262904A1 (en) 2022-09-21 2024-03-28 Elthera Ag NEW BINDING MOLECULES THAT BIND TO L1CAM
TW202417057A (zh) * 2022-10-26 2024-05-01 大陸商同潤生物醫藥(上海)有限公司 人源化的l1cam抗體藥物偶聯物
CN121941710A (zh) 2023-09-27 2026-04-28 艾尔瑟拉股份有限公司 用于治疗血液恶性肿瘤疾病的l1cam结合分子

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
US5225539A (en) 1986-03-27 1993-07-06 Medical Research Council Recombinant altered antibodies and methods of making altered antibodies
DE68927933T2 (de) 1988-09-02 1997-08-14 Dyax Corp Herstellung und auswahl von rekombinantproteinen mit verschiedenen bindestellen
US5223409A (en) 1988-09-02 1993-06-29 Protein Engineering Corp. Directed evolution of novel binding proteins
US5530101A (en) 1988-12-28 1996-06-25 Protein Design Labs, Inc. Humanized immunoglobulins
CA2053911C (en) 1989-04-21 1999-11-02 Ira H. Pastan Recombinant antibody-toxin fusion protein
US5427908A (en) 1990-05-01 1995-06-27 Affymax Technologies N.V. Recombinant library screening methods
ES2139598T3 (es) 1990-07-10 2000-02-16 Medical Res Council Procedimientos para la produccion de miembros de parejas de union especifica.
GB9015198D0 (en) 1990-07-10 1990-08-29 Brien Caroline J O Binding substance
DE69129154T2 (de) 1990-12-03 1998-08-20 Genentech, Inc., South San Francisco, Calif. Verfahren zur anreicherung von proteinvarianten mit geänderten bindungseigenschaften
DE69233697T2 (de) 1991-03-01 2008-01-24 Dyax Corp., Cambridge Verfahren zur Entwicklung von bindenden Mikroproteinen
PT100379B (pt) 1991-04-10 1999-01-29 Scripps Research Inst Bibliotecas de receptores heterodimericos usando fagomideos
DE4122599C2 (de) 1991-07-08 1993-11-11 Deutsches Krebsforsch Phagemid zum Screenen von Antikörpern
AU4953693A (en) 1992-08-25 1994-03-15 Medac Gesellschaft Fur Klinische Spezialpraparate Mbh Antibody/radioisotope conjugate for tumor diagnosis and/or therapy
US5837283A (en) 1997-03-12 1998-11-17 The Regents Of The University Of California Cationic lipid compositions targeting angiogenic endothelial cells
GB0209893D0 (en) 2002-04-30 2002-06-05 Molmed Spa Conjugate
KR100470535B1 (ko) 2002-06-27 2005-02-22 재단법인서울대학교산학협력재단 유피에이 항체 부착 이뮤노리포좀
US20040202666A1 (en) 2003-01-24 2004-10-14 Immunomedics, Inc. Anti-cancer anthracycline drug-antibody conjugates
KR20080080482A (ko) 2005-09-07 2008-09-04 메디뮨 엘엘씨 독소가 컨쥬게이트된 eph 수용체 항체
PT2845866T (pt) * 2006-10-27 2017-08-09 Genentech Inc Anticorpos e imunoconjugados e utilizações dos mesmos
WO2008151819A2 (en) * 2007-06-15 2008-12-18 Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts Treatment of tumors using specific anti-l1 antibody
AU2008201871A1 (en) * 2008-04-16 2009-11-26 Deutsches Krebsforschungszentrum Stiftung Des Oeffentlichen Rechts Inhibition of angiogenesis and tumor metastasis
WO2014100740A1 (en) * 2012-12-21 2014-06-26 Seattle Genetics, Inc. Anti-ntb-a antibodies and related compositions and methods

Similar Documents

Publication Publication Date Title
JP6875275B2 (ja) L1cam(cd17)と結合する抗体などの結合分子
TWI883044B (zh) 使用her3抗原結合分子的癌症之治療及預防
JP7781859B2 (ja) 抗ror1抗体及び関連の二重特異性結合タンパク質
KR102593409B1 (ko) Her3 항원 결합 분자
CN112867507B (zh) 新型抗sirpa抗体
CN106459199B (zh) 抗-egfrviii抗体及其用途
TWI381848B (zh) 抗纖維母細胞生長因子受體-3 (fgfr-3) 抗體及包含其之醫藥組合物
KR20200079511A (ko) Cd47 항원-결합 분자
WO2018147245A1 (ja) 抗gprc5d抗体及び該抗体を含む分子
KR102360967B1 (ko) 신규 항-네트린-1 항체
US20240294622A1 (en) Novel anti-gremlin1 antibodies
WO2016167306A1 (ja) 抗ヒトNotch4抗体
WO2022095970A1 (zh) 双特异抗体及其应用
JP2023504733A (ja) 抗clec-1a抗体及びその抗原結合性断片
KR20240021294A (ko) 항-her3 항체, 이를 함유하는 항체-약물 접합체 및 그 용도
WO2024227426A1 (zh) hROR1的抗原结合蛋白及其用途
CA2962902C (en) Binding molecules, especially antibodies, binding to l1cam (cd171)
WO2012024659A2 (en) Antibody-based constructs directed against tyrosine kinase receptors
BR112017006626B1 (pt) Anticorpo monoclonal anti-l1cam ou fragmento de ligação ao antígeno do mesmo, usos relacionados e composição farmacêutica
WO2025201493A1 (zh) Dll3结合分子及其用途
AU2024359272A1 (en) Bispecific anti-axl and anti-pd-l1 antibodies and their use in therapy, particularly in the treatment of neoplasm
HK40052624B (en) Treatment and prevention of cancer using her3 antigen-binding molecules